Advertisement
Research ArticleArticle

Comparative Metabolic Capabilities of CYP3A4, CYP3A5, and CYP3A7

J. Andrew Williams, Barbara J. Ring, Varon E. Cantrell, David R. Jones, James Eckstein, Kenneth Ruterbories, Mitchell A. Hamman, Stephen D. Hall and Steven A. Wrighton
Drug Metabolism and Disposition August 2002, 30 (8) 883-891; DOI: https://doi.org/10.1124/dmd.30.8.883

Article Information

vol. 30 no. 8 883-891
DOI 
https://doi.org/10.1124/dmd.30.8.883
PubMed 
12124305
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 5, 2002
  • Accepted April 24, 2002
  • Published online August 1, 2002.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. J. Andrew Williams1,1,
  2. Barbara J. Ring1,
  3. Varon E. Cantrell1,
  4. David R. Jones2,
  5. James Eckstein1,
  6. Kenneth Ruterbories1,
  7. Mitchell A. Hamman2,
  8. Stephen D. Hall2 and
  9. Steven A. Wrighton1
  1. 1Department of Drug Disposition, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.A.W., B.J.R., V.E.C., J.E., K.R., S.A.W.); and 2Department of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana (D.R.J., M.A.H., S.D.H.)
  1. Steven Wrighton, Department of Drug Disposition, Drop Code 0710, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis 46285. E-mail:wrighton_steven{at}lilly.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to December 2024

AbstractFullPdf
Aug 201775123
Sep 201785822
Oct 2017128827
Nov 20171117548
Dec 2017937023
Jan 20181130227
Feb 20181117416
Mar 2018214624
Apr 201829423
May 2018111726
Jun 201818216
Jul 201897433
Aug 201825728
Sep 2018113921
Oct 201829224
Nov 20181010128
Dec 201896239
Jan 2019891711
Feb 2019821515
Mar 2019981815
Apr 2019911710
May 2019602022
Jun 201939412
Jul 201944117
Aug 20191091913
Oct 2019781316
Nov 201961139
Dec 201957307
Jan 202055129
Feb 20205895
Mar 202070109
May 2020911210
Jun 20204257
Jul 20203669
Aug 20203977
Sep 2020391710
Oct 202081115
Nov 20206075
Dec 2020561815
Jan 2021437213
Feb 2021346914
Mar 202147199
Apr 202138117
May 202174346
Jun 202160426
Jul 202174227
Aug 2021744010
Sep 202192224
Oct 202194174
Nov 20219975
Dec 202197236
Jan 202261130
Feb 20228752
Mar 2022581612
Apr 202268119
May 202258158
Jun 2022771714
Jul 20228794
Aug 2022742416
Sep 202253188
Oct 202260528
Nov 2022741913
Dec 20223134
Jan 2023129268
Feb 20235995
Mar 2023931912
Apr 20235487
May 202374325
Jun 202376146
Jul 2023722910
Aug 202349388
Sep 202367127
Oct 20232091213
Nov 2023308153
Dec 2023213896
Jan 20241502813
Feb 2024108925
Mar 202497123
Apr 20241163911
May 20242514012
Jun 202464136
Jul 202462619
Aug 202492146
Sep 2024118258
Oct 2024105215
Nov 202484118
Dec 202457139

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Comparative Metabolic Capabilities of CYP3A4, CYP3A5, and CYP3A7

J. Andrew Williams, Barbara J. Ring, Varon E. Cantrell, David R. Jones, James Eckstein, Kenneth Ruterbories, Mitchell A. Hamman, Stephen D. Hall and Steven A. Wrighton
Drug Metabolism and Disposition August 1, 2002, 30 (8) 883-891; DOI: https://doi.org/10.1124/dmd.30.8.883
Twitter logo Facebook logo Mendeley logo

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Advertisement